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Changes in the equilibrium of pro- and 
anti-apoptotic members of the B-cell lymphoma-
2 (Bcl-2) protein family in the mitochondrial 
outer membrane (MOM) induce structural 
changes that commit cells to apoptosis. Bcl-2 
homology-3 (BH3)-only proteins participate in 
this process by either activating pro-apoptotic 
effectors or inhibiting anti-apoptotic components 
and by promoting MOM permeabilization. The 
association of BH3-only proteins with MOMs is 
necessary for the activation and amplification of 
death signals; however, the nature of this 
association remains controversial, as these 
proteins lack a canonical transmembrane 
sequence. Here we used an in vitro expression 
system to study the insertion capacity of 
hydrophobic C-terminal regions of the BH3-only 
proteins Bik, Bim, Noxa, Bmf, and Puma into 
microsomal membranes. An Escherichia coli 
complementation assay was used to validate the 
results in a cellular context, and peptide 
insertions were modeled using molecular 
dynamics simulations. We also found that some 
of the C-terminal domains were sufficient to 
direct green fluorescent protein-fusion proteins 
to specific membranes in human cells, but the 
domains did not activate apoptosis. Thus, the 
hydrophobic regions in the C-termini of BH3-
only members associated in distinct ways with 
various biological membranes, suggesting that a 
detailed investigation of the entire process of 
apoptosis should include studying the 
membranes as a setting for protein-protein and 
protein-membrane interactions. 
 
Apoptosis, a prevalent mechanism of 
programmed cell death, is regulated by the Bcl-2 
family of proteins. Notably, the balance between 
pro- and anti-apoptotic Bcl-2 members in the 
mitochondrial outer membrane (MOM) can 
protect or trigger MOM permeabilization 
(MOMP). The members of the Bcl-2 family can 
be divided into three groups according to their 
function and the presence of the Bcl-2 homology 
domains BH1–BH4. One type of pro-apoptotic 
Bcl-2 family proteins contains only BH3 
domain; these proteins are termed BH3-only 
proteins. Genetic experiments have shown that 
these proteins are essential initiators of 
programed cell death (1). Some BH3-only 
proteins, like Bim, Puma and Noxa, are termed 
activators, as they directly induce Bax/Bak-
dependent MOMP (2,3). Other BH3-only 
proteins, like Bik, and Bmf, are termed 
sensitizers, as they promote apoptosis by binding 
to anti-apoptotic proteins to induce the release of 
either activator BH3-only proteins (4) or 
activated Bax or Bak (5).  
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Several Bcl-2 family members can form 
membrane channels using amphipathic α-
helices, and it is widely accepted that the 
carboxyl-terminal (C-terminal) hydrophobic 
domains of these members are inserted into 
membranes thus anchoring it to intracellular 
membranes (6), such as the endoplasmic 
reticulum (ER) and the MOM, where they 
promote the release of apoptotic factors (7). 
Since the interaction with the membrane plays 
an active role in the regulation of apoptosis by 
changing the affinities of the interactions 
between partner proteins (8), it would be 
interesting to determine whether the C-terminal 
region of BH3-only members targets these 
proteins to the MOM and/or to ER membranes. 
In particular, some reports have investigated the 
anchoring capacity of BH3-only proteins to the 
MOM (9), although the existence of a 
transmembrane (TM) region is still being 
debated. 
Bcl-2 family proteins have been cloned 
and expressed for studies that used high-
resolution techniques to give us insights into the 
physiological control of apoptosis and its 
pathological consequences (10). However, most 
of these studies used truncated forms of the 
proteins that did not include their C-terminal 
hydrophobic domains. These truncated forms are 
easier to produce in the larger quantities required 
for structural studies than the full-length proteins 
with C-terminal regions; the latter, although 
more biologically relevant, are difficult to 
produce (11). A complete understanding of the 
BH3-only proteins requires studies that 
investigate the functions of their C-terminal 
hydrophobic domains. Because individual 
membrane-inserting α-helices can be considered 
true protein domains, i.e. independently-folded 
units with specific functions, the challenge of 
overexpressing and purifying full-length 
proteins can be circumvented using a 
reductionist approach. Specifically, individual 
C-terminal hydrophobic sequences from BH3-
only proteins can be used to evaluate 
experimentally the targeting and membrane 
insertion processes. 
This study examined the membrane-
insertion properties of the C-terminal 
hydrophobic regions of the human Bim, Puma, 
Noxa, Bik, and Bmf proteins. When these 
sequences were analyzed computationally, we 
found that only the C-terminal domain of Bik 
was defined a priori as a TM segment. However 
an in vitro expression system demonstrated 
insertion of other low hydrophobicity segments 
as predicted by coarse-grained molecular 
dynamics (MD) simulations. Notably, these C-
terminal domains were sufficient to determine 
the intracellular membrane location of chimeric 
proteins but did not activate an apoptotic 
response. Taken together, the results of our 
multifaceted approach suggest that BH3-only 
proteins can associate with different intracellular 





Insertion into ER-derived microsomal 
membranes – To identify the hydrophobic C-
terminal regions of the human BH3-only 
proteins Bim, Puma, Noxa, Bik, and Bmf, their 
amino acid sequences were parsed to test the 
performance of the ΔG Prediction Server 
(http://dgpred.cbr.su.se/). Given the amino acid 
sequences, this algorithm predicts the 
corresponding apparent free energy difference, 
ΔGapp, for insertion of each sequence into the ER 
membrane by means of the Sec61 translocon 
(12,13). Table 1 shows the predicted ΔGapp 
values for the C-terminal domains of the 
analyzed BH3-only proteins. The negative ΔGapp 
value for the Bik C-terminal region predicts a 
TM disposition, whereas the positive values 
computed for Bim, Puma, Noxa, and Bmf 
predict that these sequences do not integrate into 
membranes. 
Next, the membrane insertion capacity 
of these C-terminal regions was investigated 
using an experimental system based on Lep, the 
Escherichia coli inner membrane protein leader 
peptidase. This system accurately reports 
whether the TM helices are integrated into 
biological membranes. Since Bcl-2 family 
proteins are predominantly exposed to the 
cytosol and anchored to intracellular membranes 
by their C-terminal regions, in our experimental 
setup we tested the candidate sequences 
according to their predicted topology (29). The 
Lep construct that we used consisted of an 
extended N-terminal sequence of 24 residues 
that carries an acceptor site for N-linked 
glycosylation (G1), followed by two TM 
segments (H1 and H2) connected by a cytosolic 
loop (P1) then a large C-terminal domain (P2) 
that contains a second glycosylation site (G2) 
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(Fig. 1A). This model membrane protein inserts 
into ER-derived microsomal membranes such 
that both termini are located in the lumen, 
allowing co-translational modification of the 
designed acceptor sites G1 and G2 by the 
luminal oligosaccharide transferase activity (Fig. 
1A). The BH3 C-terminal sequences that we 
analyzed (BH3-Ct) replaced the Lep H2 domain. 
In our system, the glycosylation site (G2) 
located in the first part of the P2 domain can 
only be modified if the C-terminal domain is 
translocated across the membrane; in contrast, 
the G1 site, which is embedded in an extended 
N-terminal sequence, will always be 
glycosylated. Single glycosylation (i.e. non-
integration of the tested sequence) results in a 
molecular mass increase of ~2.5 kDa relative to 
the observed molecular mass of Lep when it is 
expressed in the absence of microsomes; upon 
double glycosylation (i.e. membrane insertion of 
the tested sequence), the molecular mass shifts 
by ~5 kDa. When proteinase K (PK) is added to 
the microsomal vesicles, it digests the non-
glycosylated form of the P2 domain that is 
exposed to the cytoplasm (Fig. 1A, right); 
alternatively, it produces a protected, 
glycosylated BH3-Ct/P2 fragment when the P2 
domain is located in the lumen of the 
microsomal vesicles (Fig. 1A, left). 
In the presence of microsomes, the 
translation of constructs harboring the Bik C-
terminal region (constructed as described 
previously (30,31)) resulted mainly in double 
glycosylated forms of the protein (Fig. 1B, lane 
5). PK treatment of these samples yielded a 
protected glycosylated Bik-Ct/P2 fragment (lane 
6), indicating that the Bik C-terminal region was 
inserted into the membrane. Similar results were 
obtained with constructs harboring the Bmf C-
terminal region (Fig. 1C, lanes 7–9). In this case, 
contrary to the ΔGapp prediction (Table 1), the C-
terminal region of Bmf was inserted efficiently 
into the membrane (>60% of the molecules were 
double glycosylated, with quantification 
performed as described previously (32)). 
Regarding the Bim C-terminal region, we found 
that less than one-fourth of the molecules were 
inserted into biological membranes (Fig. 1B, 
lanes 7–9), in good agreement with previous 
reports in which a portion of the GFP/Bim-Ct 
fusions localized to the ER membranes (9). 
Similarly, the Puma C-terminal domain was 
inserted into microsomal membranes more 
efficiently than predicted, since up to one-third 
of the molecules were double glycosylated. 
Finally, in the presence of microsomal vesicles, 
the Noxa C-terminal region was single 
glycosylated and sensitive to PK digestion (Fig. 
1C, lanes 4–6), indicating non-TM disposition. 
Insertion into E. coli cellular 
membranes – The microsomal in vitro system 
closely mimics the conditions of in vivo 
membrane protein assembly. The C-terminal 
regions of Bik, Bmf, and, to a lesser extent, 
Puma and Bim were recognized in vitro by the 
translocon as TM segments out of their native 
contexts (Fig. 1). We next investigated whether 
these BH3-only C-terminal regions could direct 
protein integration into biological membranes in 
a cellular context. Towards this end, we used an 
insertion/topology assay into the E. coli inner 
membrane that is based on the function of 
maltose-binding protein (MBP) in the maltose 
transport pathway. E. coli MM39 cells, which 
lack endogenous MBP, cannot transport maltose 
into the cytoplasm for metabolism. 
Consequently, they cannot grow on media in 
which the only available carbon source is 
maltose (17). If the chimeric ToxR(BH3-
Ct)MBP is correctly inserted into the inner 
membrane (Fig. 2A), the periplasmic MBP 
domain will complement the MM39 malE-
deficient phenotype and support cell growth on 
maltose (15). To demonstrate the requirement 
for periplasmic localization of MBP in the 
complementation assay we used constructs 
harboring pro-apoptotic Bax or anti-apoptotic 
Bcl-2 C-terminal (α9) TM segments (33) as 
positive controls and a construct lacking a TM 
segment (ΔTM) as a negative control. These 
three controls plus constructs harboring BH3-
only C-terminal regions were transformed into 
MM39 cells and cultured on M9-maltose media, 
which has maltose as the only carbon source. As 
shown in Figure 2B, cells expressing the C-
terminal regions of Bax, Bcl-2, Bik, and Bmf 
grew on M9-maltose media. These results 
demonstrate that both the Bik and Bmf C-
terminal-containing constructs anchor their MBP 
domains to the E. coli inner membrane in the 
correct orientation, which is consistent with the 
insertion data obtained with the microsomal 
system. In contrast, cells that lacked a TM 
segment or that contained the Bim, Puma, or 
Noxa C-terminal regions failed to grow. The 
expression of all constructs was verified by 
growing the cells in complete media with the 
appropriate antibiotic selection and by 
immunobloting, using antibodies directed 
against MBP (Fig. 2C). It should be mentioned 
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that the C-terminal regions of murine Bim, 
Puma, and Noxa target chimeric proteins to the 
mitochondrial membranes, and alkaline 
extraction experiments suggest membrane 
insertion rather than peripheral association (9). 
These apparent discrepancies with our data 
obtained for human BH3-only protein regions in 
prokaryotic cells suggest that in addition to 
sequence differences, there may be eukaryotic 
proteins or lipid factors that actively assist in the 
insertion of these three hydrophobic regions into 
the mitochondrial membranes. 
Molecular dynamics simulations of 
peptide insertion – To help us interpret the 
protein insertion data, we carried out molecular 
dynamics simulations of the C-terminal regions 
from the same five BH3-only proteins (Bik, 
Bmf, Bim, Noxa, and Puma) plus the H2 domain 
from Lep in the presence of DOPC lipids. To 
test the intrinsic tendency of these peptides to 
insert into lipid membranes, we set up self-
assembly simulations for each protein sequence 
in the presence of DOPC lipids using the 
MARTINI coarse-grained force field (18,19) 
assuming an α-helical secondary structure. The 
amino acid sequence of Puma C-terminal 
hydrophobic region contains proline residues at 
position 167 and 180 (residue position in human 
full-length Puma sequence, Table 1), so we 
restricted the helical secondary structure to the 
segment between the proline residues. In all 
cases, the systems consisted of one copy of the 
helical peptide, 200 DOPC lipids, and 2180 
water particles, all placed in random positions 
and orientations. In MARTINI simulations, 
spontaneous lipid self-assembly is observed on 
short time scales (tens of nanoseconds) due to 
the very strong driving force (the hydrophobic 
effect), while the tendency of peptides to be 
incorporated into a membrane or onto a 
membrane surface (Fig. 3A) depends essentially 
on the amino acid sequence (19). As shown in 
Figure 3B, some peptides, namely Lep-H2, Bik, 
and Bmf, showed a strong tendency to associate 
with the lipid membrane and assume a TM 
orientation (>50% of the cases, Table 1). These 
were inserted in a TM orientation with over 50% 
probability. The remaining three peptides, from 
Bim, Noxa, and Puma, also showed a tendency 
to insert in a TM orientation, although to a lesser 
extent (about 40% probability). The agreement 
with experimental data is reasonable for all of 
the peptide sequences except for Puma and 
Noxa. However, in the case of Puma, the 
simulations predicted a very favorable 
probability of insertion if a completely helical 
secondary structure is assumed and a much less 
favorable probability of insertion for a partially 
helical conformation (see Table 1). Notably, our 
simulation methodology did not allow 
predictions of secondary structure, and peptide 
insertion prediction depends on the secondary 
structure of the analyzed peptide. For Noxa we 
assumed a completely helical secondary 
structure, and the simulations predicted a 
significant probability of insertion (close to 40% 
probability), but no insertion was observed 
experimentally (Figs. 1 and 2). We hypothesize 
that this discrepancy can be explained by an 
incorrect (overestimated) prediction of the 
secondary structure of Noxa. That is, as 
observed for Puma, if the peptide is not fully 
helical, then insertion may be reduced due to the 
higher polarity of the peptide backbone. 
Intracellular localization of BH3-only 
proteins and apoptotic activity in human cells  –  
There is emerging evidence that the interactions 
of BH3-only proteins with membranes regulate 
their binding to other Bcl-2 family members, 
thereby determining their function (34). 
Intracellular targeting and localization of the 
human BH3-only C-terminal regions were 
evaluated using GFP/BH3-only C-terminus 
(GFP/BH3-Ct) fusion proteins. Mitotracker dye 
and the Grp78 protein were used to analyze the 
ability of the BH3-only C-terminal regions to 
target a reporter GFP moiety to different cellular 
organelles in HeLa cells (Fig. 4). 
A GFP/Bcl-2 C-terminal fusion protein 
was used as a positive control for mitochondrial 
targeting (Fig. 4A). However, some authors have 
postulated that a fraction of Bcl-2 protein 
molecules also localize to the ER membrane 
(35), which is what we observed (Fig. 4B). The 
C-terminus of human Bim was sufficient for 
mitochondrial localization of GFP (Fig. 4A), 
although a portion of GFP/Bim-Ct localized to 
the ER membranes (Fig. 4B). GFP/Puma-Ct 
showed similar targeting, whereas the C-
terminus of human Bik targeted GFP to the ER, 
as suggested by previous studies (9,36) (Fig. 4). 
The C-terminus of human Noxa had no clear 
membrane-targeting activity (Fig. 4), which is 
consistent with our membrane-insertion data and 
with results from a recent study demonstrating 
that this C-terminal tail serves as a degradation 
signal in a non-membrane related process (37). 
The Bmf C-terminal domain showed efficient 
membrane insertion capacity in vitro, in vivo, 
and in silico (Figs. 1–3); however, GFP/Bmf-Ct 
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showed a cytosolic pattern rather than 
localization to the mitochondrial membrane 
(Fig. 4A) or to the ER (Fig. 4B).  
The biochemical function of BH3-only 
proteins as essential initiators of intrinsic 
apoptosis has been largely analyzed (34). 
However, the role played by their C-terminal 
hydrophobic regions remains controversial. 
Previous studies have demonstrated that in the 
absence of the rest of the protein, the C-termini 
of some Bcl-2 family members can destabilize 
the MOM (38) and/or generate pores (39) that 
release apoptogenic components. More recently, 
we reported that C-terminal TM peptides from 
different Bcl-2 family proteins enhance the 
apoptotic pathway induced by chemotherapeutic 
agents (7). To test the function of these BH3-
only C-terminal regions, we examined whether 
GFP/BH3-Ct fusions induced apoptosis by 
measuring caspase activation and cytochrome c 
(cyt c) release. As shown in Figure 5, 
overexpression of the GFP/BH3-Ct fusions in 
HeLa cells did not induce significant caspase-
like activity in either case. In addition, we found 
no evidence of cyt c release by confocal 
microscopy (data not shown). Collectively, these 
results show that overexpression of the C-
termini of these BH3-only proteins did not 
induce apoptosis in healthy cells, indicating that 
the activator or sensitizer activities of BH3-only 
proteins may require intra-molecular interactions 
between the C-terminus and the soluble domain 





Structural and biophysical studies have 
been invaluable in deciphering the role of BH3-
only proteins in apoptosis (40), but gaps remain 
in our knowledge, especially concerning the 
ways in which BH3-only proteins influence 
Bax/Bak membrane associations (41). BH3-only 
proteins are crucial in the regulation of 
apoptosis, either by inhibiting anti-apoptotic 
Bcl-2 family members or by directly activating 
the pro-apoptotic effectors Bax and Bak (42). In 
this dual action mechanism, the membrane 
association and intracellular distribution of BH3-
only proteins, especially their MOM 
localization, can be critical. Towards this end, 
the C-terminal hydrophobic regions can play a 
key role in the targeting and sorting of BH3-only 
proteins. These C-terminal regions have 
moderate to low hydrophobicity scores, except 
for the Bik protein, but this does not preclude 
their insertion into lipid membranes (Figs. 1–3). 
Notably, all of the C-terminal sequences that we 
analyzed lacked the flanking positively-charged 
residues that have been extensively described as 
mitochondrial targeting signals (43).  
Our results showed that the C-termini of 
the sensitizers Bik and Bmf, and to some extent, 
those of Puma and Bim, were inserted into 
biological membranes in vitro. Similar results 
were obtained in the bacterial maltose-
complementation system and in coarse-grained 
simulations. The presence of proline residues 
within the hydrophobic region of Puma may 
actually introduce kinks into the helical 
structure, thereby increasing the polarity for the 
peptide backbone carbonyl groups about three 
and four residues N-terminal of the proline 
location within the helices (44). Increasing the 
backbone polarity reduces the insertion 
efficiency of TM helices (45,46). This was 
confirmed by simulations, which showed that a 
reduced helical length decreased the probability 
of peptide insertion (Table 1). The dispersion of 
charged residues, especially in the case of the 
Bim C-terminal sequence, would explain the 
predicted penalty for insertion into the core of 
the bilayer (Table 1). Nevertheless, the 
hydrophobic contribution of the neighboring 
residues in this sequence may compensate, at 
least partially, for the free energy cost of 
inserting charged residues into the membrane, as 
observed previously for some model 
hydrophobic/cationic sequences (30). This 
would allow the level of insertion that we 
observed. In the case of the C-terminal sequence 
of Noxa, its short hydrophobic region could 
explain why it was not inserted into the 
membrane, since the biophysics of hydrophobic 
mismatch control insertion through the Sec61 
translocon of short helices into the ER 
membrane (46,47). 
When these BH3-only C-terminal 
regions were tested in healthy human cells, some 
differences were observed. In terms of 
intracellular localization and insertion, the Bik 
C-terminus was targeted and inserted into the 
ER membrane (Fig. 4), in good agreement with 
previous reports (9,36). Similar to murine 
sequences, the C-termini of human Bim and 
Puma appeared to target GFP/Bim-Ct and 
GFP/Puma-Ct fusion proteins to organelle 
membranes (i.e. to mitochondrial and ER 
membranes), whereas the rest of the Bim and 
Puma proteins, i.e. the soluble domains, are 
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probably required for efficient mitochondrial 
localization. Interestingly, the GFP/Bim full-
length construct co-localizes with the MOM 
marker protein Tom20, while constructs 
containing only the C-terminal stretch of Bim 
localize to membranes, but not specifically to 
mitochondrial membranes (48), which is in good 
agreement with current observations (Fig. 4). 
This intracellular distribution correlates with 
their apoptotic function as direct activators of 
Bax and Bak in the MOM (49).  
The GFP/Noxa-Ct fusion protein 
showed a punctate pattern on fluorescence 
microscopy (Fig. 4). Together with our in vitro 
and in vivo data on protein insertion (Figs. 1 and 
2) and recent studies suggesting that the C-
terminus of Noxa regulates protein stability 
through an ubiquitin-independent mechanism 
(37), it is reasonable to propose that the C-
terminus of human Noxa has no membrane 
targeting/insertion activity. Finally, in contrast to 
what we found in our membrane insertion assays 
and molecular dynamics simulations, the 
cytosolic distribution of GFP/Bmf-Ct indicated 
that the C-terminus of human Bmf did not 
contain membrane-targeting information in the 
absence of apoptotic signals. In fact, the 
sensitizer Bmf has been proposed to be largely 
unstructured under physiological conditions and 
to undergo a conformational change when it is 
bound to anti-apoptotic proteins in solution (50). 
Coupled folding and binding could help displace 
the BH3-only C-terminal domain and target the 
complex to intracellular membranes (51) in 
which the Bmf C-terminal region is inserted. In 
fact, some Bmf isoforms containing the C-
terminal hydrophobic region have been found 
preferentially in the MOM in healthy cells (52). 
The human Bik, Noxa and Bmf C-
terminal domains that we analyzed were 
localized mainly to the ER membranes and the 
cytosol, suggesting that some BH3-only proteins 
require their soluble domains and/or the 
recruitment of additional factors to reach the 
MOM (42). Furthermore, physical interactions 
between the ER and mitochondrial membranes 
could allow lateral diffusion of apoptotic signals 
through BH3-only C-terminal domains that are 
inserted in ER membranes (53).  
To summarize, BH3-only proteins exert 
their pro-apoptotic function in different ways, 
and their C-terminal regions have different 
capabilities in terms of targeting and insertion 
into intracellular membranes. Once in the MOM, 
interactions between the BH3-only C-terminal 
hydrophobic regions with the TM segments 
from pro-apoptotic (Bax or Bak) and/or anti-
apoptotic (Bcl-2, Bcl-xL, etc.) proteins could 
modulate mitochondrial apoptosis signaling, 
most likely by directly or indirectly promoting 
MOM pore formation. Further studies are 
needed to fully elucidate the mechanisms that 
control the apoptotic activation mediated by 
BH3-only proteins. Such studies should focus on 
the membrane environment in order to expand 




Computer-assisted analyses of BH3-only 
protein sequences – Putative insertion of 
hydrophobic regions from BH3-only proteins 
was predicted using the ΔG Prediction Server 
v1.0 (http://dgpred.cbr.su.se/) using standard 
parameters combined with subsequent detection 
of the lowest apparent free energy differences 
(ΔGapp values) (12,13). The complete protein 
sequences were obtained from UniProt 
(http://www.uniprot.org). 
Enzymes and chemicals – All enzymes, 
as well as plasmid pGEM1, and the TNT SP6 
Quick Coupled System were from Promega 
(Madison, WI, USA). ER rough microsomes 
from dog pancreas were from tRNA Probes 
(College Station, TX, USA). [35S]Met/Cys was 
from Perkin Elmer, and restriction enzymes 
were purchased from Roche Molecular 
Biochemicals unless otherwise stated. The DNA 
purification kits were from Thermo Fisher 
Scientific (Ulm, Germany). All oligonucleotides 
were purchased from Sigma-Aldrich 
(Switzerland). 
DNA manipulations – For the expression 
of Lep-derived constructs containing human 
BH3-only protein C-termini from the pGEM1 
plasmid, the Lep sequence carried one 
glycosylation acceptor site at positions 3–5 of an 
extended sequence of 24 residues that was 
described previously (14). Oligonucleotides 
encoding the different BH3-only C-terminal 
hydrophobic regions were introduced by 
replacing the Lep H2 TM segment. Pairs of 
complementary oligonucleotides (25 μM ) were 
first annealed at 85 °C for 10 min in annealing 
buffer (20 mM Tris-HCl, 20 mM MgCl2, 500 
mM NaCl) followed by slow cooling to 30 °C, 
after which the two annealed double-stranded 
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oligonucleotides were mixed, incubated at 65 °C 
for 5 min, cooled slowly to room temperature, 
purified and treated with polynucleotide kinase 
at 37ºC for 30min. The annealed 
oligonucleotides with SpeI/KpnI restriction sites 
flanking the hydrophobic sequence were ligated 
overnight with T4 DNA ligase (Promega) at 
16°C into purified pGEM-Lep plasmid digested 
with SpeI/KpnI and treated with alkaline 
phosphatase (Promega). All BH3-derived 
segment inserts were confirmed by sequencing 
the plasmid DNA. 
To generate maltose-complementarity 
chimeric constructs, DNA oligonucleotides 
encoding the putative TM regions of BH3-only 
proteins were designed and cloned into the 
pGL3 ToxR-HA-MBP plasmid as described 
above, in this case the TM sequences were 
flanked by HindIII/XhoI restriction sites. 
The BglII and EcoRI sites were used as 
cloning sites for the GFP/BH3-Ct fusions. A 
template containing all the putative TM 
sequences flanked with BglII/EcoRI was created 
with the Gene-art gene synthesis service of 
Thermo-Fisher Scientific. After PCR 
amplification, the PCR products were purified, 
digested, and ligated to the corresponding GFP 
vector (Addgene #17999) that had been digested 
with BglII and EcoRI using standard molecular 
biology protocols. All of the ligated constructs 
were transformed into E. coli DH5α 
electrocompetent cells, incubated in SOC for 45 
minutes at 37°C, pelleted at 3,000×g, and plated 
directly onto LB agar petri dishes containing 
ampicillin (50 μg/ml). After 24 h, positive 
colonies were isolated and cultured on LB 
medium with ampicillin for 24 h at 37°C. 
Plasmid DNA was isolated using the GeneJet 
Plasmid miniprep kit (ThermoFisher Scientific) 
for sequencing analysis. All new constructs were 
confirmed by DNA sequencing. 
In vitro transcription/translation assays 
– The pGEM1-derived constructs were 
transcribed and translated using the TNT SP6 
Quick Coupled System (Promega). The 
reactions contained 75 ng DNA template, 0.5 μL 
35S-Met (5 μCi), and 0.25 μL microsomes (tRNA 
Probes) and were incubated for 90 min at 30°C. 
The translation products were ultracentrifuged 
(100,000×g for 15 min) on a sucrose cushion, 
and analyzed by SDS–PAGE. The bands were 
quantified using a Fuji FLA-3000 
phosphoimager and Image Reader 8.1j software. 
The membrane-insertion probability for a given 
BH3-segment was calculated as the quotient of 
the intensity of the double glycosylated band 
divided by the summed intensities of the single 
glycosylated band plus the double glycosylated 
band. 
For the proteinase K protection assay, 2 
μL of proteinase K (1 mg/mL) was added to the 
sample, and the digestion reaction was incubated 
for 15 min on ice. Before SDS-PAGE analysis, 
the reaction was stopped by adding 1 mM 
phenylmethanesulfonylfluoride. 
ToxR/BH3-Ct/MBP complementation 
assay – The design and expression of chimeric 
ToxR/maltose binding protein (MBP) harboring 
BH3-only C-terminal regions in E. coli MM39 
cells have been described previously (15-17). 
Constructs were introduced into chemically 
competent MM39 cells and plated onto M9 agar 
plates containing 0.4% maltose, 1% ion agar, 
and ampicillin (50 μg/mL). For Western blots, 
MM39 transformants were grown for 2h in LBA 
liquid media. Cells were lysed by three rounds 
of freeze–thawing in TBS buffer containing 1% 
NP-40. The lysates were mixed with SDS-PAGE 
sample buffer, heated to 95°C for 5 min, 
separated on 12% (w/v) mini-gels, blotted onto 
nitrocellulose membranes, and the membranes 
were blocked with skim milk. The ToxR(BH3-
Ct)MBP chimera were detected with HRP-
conjugated anti-MBP monoclonal antibody 
(New England Biolabs) and ECL reagent (GE 
Healthcare). Chemiluminescence was visualized 
using an ImageQuant LAS 4000 (GE 
Healthcare). 
 
Molecular dynamics simulations – All-
atom structures for the 6 peptides were 
generated using Modeller (v9.12). The structures 
were converted to the MARTINI coarse-grained 
representation (18,19) using standard scripts that 
are available on the MARTINI website 
(http://md.chem.rug.nl/). For self-assembly 
simulations, we used cubic simulation boxes 
(8.5-nm lateral size) filled with 1 peptide, 200 
DOPC lipids, and 2180 water particles 
distributed randomly. The D-conformation of the 
peptides was fixed. For Puma, we performed an 
additional set of simulations in which only 
residues 5–14 were in a helical conformation. 
For each peptide, 100 copies of the simulation 
system were prepared, each one with a different 
random distribution. Moreover, two sets of 
simulations were performed that used the same 
setup but different versions of the force field i.e. 
the “standard” v2.2 and v2.2P, including the 
MARTINI polarizable water model (20). The 
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total number of simulations was 100*2 for each 
peptide. 
All simulations were carried out with 
the GROMACS (v5.0) software package 
(21,22). The Verlet cut-off scheme (using 
buffered neighbor lists) was used for the 
calculation of non-bonded interactions (23). 
Non-bonded forces were calculated with a cut-
off of 1.1 nm and shifted functions (24). The 
dielectric constant was set to 15 when using the 
standard MARTINI water model and to 2.5 
when the polarizable force field was used (20). 
In simulations with the polarizable water model, 
the PME method was used for the calculation of 
long-range electrostatics (25,26). The leap-frog 
algorithm was used for integration of the 
equation of motion with a time step of 20 fs. The 
Bussi-Donadio-Parrinello thermostat (27) was 
used to maintain a constant temperature of 300 
K with a time constant of 1 ps. All simulations 
were carried out in two steps. During the first 
step, isotropic pressure coupling was applied 
(Berendsen algorithm (28), pressure of 1 bar, 
time constant of 5 ps, compressibility of 4*10-5 
bar-1). The membrane self-assembled during this 
step, and at the end of the step, the system was 
rotated to align the membrane normal to the Z 
axis. In the second simulation step, semi-
isotropic pressure coupling was used with the 
same parameters as in the first step to allow 
peptide reorientation in or on a tension-less 
membrane. The duration of each simulation 
steps was 100 ns for the standard MARTINI 
model (total simulation time: 7*100*2*100 ns = 
140 µs) and 500 ns for the polarizable model 
(total simulation time: 7*100*2*500 ns = 700 
µs). 
Cell lines and cultures – Human cervix 
adenocarcinoma (HeLa) cells were obtained 
from the ATCC. Cells were grown at 37°C in a 
5% CO2 atmosphere in Dulbecco’s modified 
Eagle’s medium plus 10% FBS (GIBCO BRL 
Life Technologies). The GFP protein was fused 
at the N-terminus of the putative TM regions of 
the different BH3-only proteins as described 
above, and constructs were transfected using 
LipofectamineTM 2000 (Invitrogen) following 
the manufacturer’s protocol. 
Immunofluorescence of GFP/BH3-Ct 
fusions in HeLa cells – For confocal 
microscopy, 2×105 HeLa cells were seeded on 
glass coverslips to reach 50% confluence the 
next day. The cells were transfected as indicated 
below. To analyze the mitochondrial localization 
of the GFP/BH3-Ct fusions, HeLa cells were 
incubated at 37ºC with Mitotracker red dye 500 
nM (Thermo scientific ref. M7512) and DAPI 
(4’,6-diamidino-2-phenylindole, Thermo 
scientific ref. D1306) for 30 min. Microscopic 
images of living cells were taken 24 hours after 
transfection using confocal microscopy at 25ºC 
(Leica TCS SP2 AOBS) with a 63x oil 1.4 
objective, using zoom 3 and 1024x1024 pixels 
resolution. Immersion oil Leica Type F (ref. 
11513859) with refractive index at 22ºC 
n=1.5180. Blue diode laser for 405nm, laser 
He/Ne 594nm. Argon laser for 488nm 
excitation. 
For the ER localization and cyt c release 
assay, after cell attachment, cell spreading, and 
transfection with the GFP/BH3-Ct constructs, 
HeLa cells were fixed with 4% 
paraformaldehyde for 20 min. After three 
washes with PBS, cells were permeabilized with 
0.1% Triton X-100 for 10 min and blocked in 
2% gelatin PBS for 30 min. Cells were then 
labeled with antibodies against cyt-c (1:200; 
SC13561; Santa Cruz) and Grp78 protein 
(1:400; ab21685; Abcam) in PBS plus 2% 
gelatin followed by incubation with an anti-
mouse IgG-Alexa 555 (1:400) secondary 
antibody also in PBS plus 2% gelatin 
(Invitrogen). Coverslips were mounted on glass 
slides with 5 μL of Mowiol/Dapi (nuclear 
marker, 5 μg/ml) (Sigma). Images were obtained 
using confocal microscopy (see above) with a 
63x objective (green channel, λexc 488 nm, λemi 
515 nm; red channel, λexc 561 nm, λemi 598 nm). 
Fluorescence images were analyzed with ImageJ 
1.46i “JACoP plugin” with contrast and gamma 
adjustments according to the provider’s 
instructions. All background fluorescence was 
eliminated to avoid false-positives. Co-
localization was defined as completely 
overlapping or partially overlapping signals. All 
experiments were repeated three times. At least 
30 images of each sample were analyzed. 
Immunoblotting the GFP/BH3-Ct fusion 
proteins in HeLa cells – After 24 h of GFP/BH3-
Ct transfection, whole cell extracts were 
obtained by lysing cells in buffer containing 25 
mM Tris-HCl pH 7.4, 1 mM EDTA, 1 mM 
EGTA, 1% SDS, and protease and phosphatase 
inhibitors. The total protein was quantified using 
the BCA protein assay kit (Thermo Scientific), 
and 50 μg of the whole protein extract was 
dissolved in protein loading buffer (Tris-HCl pH 
6.8, 10% w/v SDS, 250 mM DTT, 0.03% w/v 
bromophenol blue, and 50% v/v glycerol) and 
boiled 5 min at 95ºC. Proteins were resolved by 
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SDS-PAGE (acrylamide 12%) and transferred to 
nitrocellulose membranes, and the membranes 
were blocked with 5% non-fat milk, washed 
three times with TBS-Tween 20 (0.1%), and 
incubated overnight at 4°C with specific primary 
antibodies against GFP (1:1000, ab13970, 
Abcam) and α-tubulin (1:1000, #T8203, Sigma-
Aldrich). The membranes were then washed 
with TBS-Tween 20 (0.1%) and probed with the 
appropriate secondary antibody: α-mouse 
(1:3000, A4937, Sigma) or α-rabbit 
(1:3000,A0545, Sigma) conjugated to 
horseradish peroxidase for enhanced 
chemiluminescence detection (Amersham 
Pharmacia Biotech). 
Caspase-like activity assay – All cell 
extracts were prepared from 2×105 cells that 
were seeded in 6-well plates. After 24 h, cells 
were treated and/or transfected as indicated 
above; 24 h after this, the cells were scraped, 
washed with PBS, and collected by 
centrifugation at 500×g. The pellets were 
resuspended in caspase assay buffer (PBS with 
10% glycerol, 0.1 mM EDTA, and 2 mM DTT) 
supplemented with protease inhibitor cocktail 
(Sigma) and kept on ice for 5 min. The pellets 
were frozen and thawed three times in liquid 
nitrogen, the cell lysates were centrifuged at 
14,000 rpm for 5 min, and the supernatants were 
collected. Quantification of the total protein 
concentration was performed using the BCA 
protein assay kit. Total protein (50 µg) was 
mixed with 200 µL of caspase assay buffer (PBS 
with 10% glycerol, 0.1 mM EDTA, and 2 mM 
DTT) containing 20 µM of the Ac-DEVD-AFC 
(Enzo Life Sciences) caspase-3-specific 
substrate. Caspase activity was monitored 
continuously following the release of fluorescent 
AFC at 37°C using a Wallac 1420 Workstation 
(λexc, 400 nm; λem, 508 nm). Caspase-3 
activity was expressed as the increase of relative 
fluorescence units per min (A.U.) 
Statistical analyses – Bars represent the 
mean ± s.d. of at least three independent 
experiments. 
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Figure 1. Insertion of BH3-only C-termini into microsomal membranes. (A) Schematic of the 
engineered leader peptidase (Lep) model protein. G1 and G2 denote artificial glycosylation 
acceptor sites. (B) and (C) In vitro protein translation in the presence (+) or absence (−) of rough 
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microsomes (RM) and proteinase K (PK). Non-glycosylated protein bands are indicated by a 
white dot; single and double glycosylated protein bands are indicated by one or two black dots, 
respectively. A black triangle indicates protected glycosylated H2/P2 or BH3-Ct/P2 fragments. 
Figure 2. The maltose complementation assay for transmembrane insertion and orientation. (A) 
Schematic of the engineered cytoplasmic ToxR and periplasmic maltose binding protein (MBP) 
domains that were fused to BH3-only protein C-terminal regions at the N- and C-termini, 
respectively. (B) malE-deficient E. coli MM39 cells were transformed with the indicated 
expression constructs and cultured on M9 agar containing 0.4% maltose. (C) Expression of all 
constructs was verified by growing the MM39 malE-deficient E. coli cells in complete LB media 
with the appropriate antibiotic selection (ampicillin), and by Western blot analysis (anti-MBP) of 
the constructs containing apoptotic C-terminal regions (bottom panel). Positive controls, 
ToxR(Bax α9)MBP and ToxR(Bcl-2 α9)MBP; negative control, ToxR(ΔTM)MBP. 
Figure 3. (A) Snapshots from molecular dynamics (MD) simulations of Bik in DOPC lipids. The 
peptide can show interfacial (top) or transmembrane (bottom) orientation. (B) Peptide orientation 
distributions. For each peptide and for each simulation, we calculated the component of the 
principal axis of inertia in the direction of the membrane normal (defined as the Z direction) at the 
end of the self-assembly simulation. If the peptide has a transmembrane orientation (yellow), its 
principal axis of inertia has a Z component close to 1; if the peptide lies parallel to the membrane 
surface (gray), the Z component is close to 0. Each plot shows the distribution of the Z component 
of the principal axis of inertia in all self-assembly simulations (100 for each peptide).  
Figure 4. Intracellular localization of GFP/BH3-Ct fusions as analyzed by confocal microscopy. 
The C-terminal sequences (Table 1) of BH3-only proteins were fused to the C-terminus of GFP 
and the constructs were transiently expressed in HeLa cells. Intracellular localization of the 
GFP/BH3-Ct fusion proteins (green channel) was analyzed by microscopy. Cells were incubated 
with Mitotracker (A) and anti-Grp78 (B) as mitochondrial and ER markers, respectively (red 
channel). Co-localizations are shown in yellow. The images in boxes are shown at higher 
magnification in the last column (inset). The bars represent either 20 μm or 2 μm (inset). 
Figure 5. GFP/BH3-Ct fusions do not promote apoptosis activation in healthy cells. Caspase-3/7-
like activity was measured in HeLa cells. Bars represent the means of three experiments ± s.d. 
ABT-263 (10 μM) was used as a positive control for apoptosis induction. The Western blots 
(bottom) used antibodies to GFP and α-tubulin as loading controls. 
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Table 1: Thermodynamic cost of BH3-only C-terminal domains integration. Analyzed 
protein sequences using ΔG Prediction Server v1.0 (http://dgpred.cbr.su.se/). Subsequences with 
lowest ΔG marked in orange as predicted by the algorithm. ΔG values are expressed in kcal/mol, 
both for the predicted (third column) and the experimental data (forth column). Negative and 
positive ΔG values are shown in green and red, respectively and denote spontaneous insertion or 
non-insertion, respectively. The probability of insertion (Pi) has been calculated from the 
experimental data as previously described (12,32). Predictions of peptide insertion based on MD 
simulations with the MARTINI model (fifth and sixth columns). Probabilities (%) are calculated 
simply from counting the instances of TM vs. interfacial peptide orientation observed in the 
simulations. M2.2 indicates MARTINI v2.2, while M2.2P indicates MARTINI v2.2 with 
polarizable water and long-range electrostatics (see Methods). Puma simulations for fully helical 
peptides were compared with the simulations of peptides in which the helix was restricted 
(probabilities in parenthesis) to the residues found between Pro167 and Pro180 (shown in bold) 
from human sequence. Probabilities above and below 50% are shown in green and red, 
respectively, for consistency. 
 
Protein Sequence pred ΔGapp exp ΔGapp Pi (%) M2.2 sim M2.2P sim 
Lep-H2 WLETGASVFPVLAI VLIVRSFIY −0.0 −1.1 85.9 60 68 
Bik-Ct LLALLLLLALLLPLLSGGLHLLL −2.9 −0.8 77.8 68 67 
Bim-Ct EDHPRMVI LRLLRYI VRLVWRMH +2.8 +0.7 23.2 45 42 
Noxa-Ct FGDKLNFRQKLLNLI SKLFCSGT +5.5 +2.6 1.4 37 43 
Bmf-Ct QNRVWWQI LLFLHNLALNGEENR +2.1 −0.3 60.4 65 57 
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